首页> 外文期刊>Health & social care in the community >The perceptions of and disincentives for receiving influenza A (H1N1) vaccines among chronic renal disease patients in Hong Kong
【24h】

The perceptions of and disincentives for receiving influenza A (H1N1) vaccines among chronic renal disease patients in Hong Kong

机译:在香港的慢性肾脏病患者中接受甲型H1N1流感疫苗的看法和抑制措施

获取原文
获取原文并翻译 | 示例
           

摘要

This article aims to demonstrate the perceptions of patients with chronic renal disease in Hong Kong towards the new vaccine for influenza A (H1N1), as well as the main disincentives. Little is known about the views of chronically ill patients on the H1N1 vaccine and even less about the underlying factors that motivate its low acceptance by this group. To explore these issues, this study adopted a qualitative approach by conducting in-depth, semi-structured interviews with 40 chronic renal disease patients in Hong Kong from December 2009 to March 2010. The participants were selected by purposive sampling from a patient with renal disease self-help alliance, which has over 4000 members with chronic renal diseases coming from nine public hospitals. Data were analysed using thematic content analysis. Although vaccination was portrayed as one of the most effective methods to prevent influenza A (H1N1), chronically ill participants in this study showed reluctance towards it. Six disincentives for them to receive H1N1 vaccines were identified: perceptions of H1N1 vaccine as unsafe, cultural perception of vaccines as harmful, the belief that seasonal influenza vaccines provided immunity against influenza A (H1N1), inaccessibility for receiving the H1N1 vaccine, worries in contracting infectious diseases from vaccination locations and the financial cost. As chronically ill patients are one of the high-risk groups who can suffer from severe complications from influenza, understanding the underlying social, cultural and perceptual factors that prevent their immunisation is crucial to the design of a public health policy responsive to their needs.
机译:本文旨在证明香港慢性肾脏病患者对新型甲型H1N1流感疫苗及其主要抑制因素的看法。对于慢性病患者对H1N1疫苗的看法知之甚少,而导致这一人群对该疫苗接受率低的根本因素则知之甚少。为了探讨这些问题,本研究采用定性方法,于2009年12月至2010年3月对香港的40例慢性肾病患者进行了深入,半结构化的访谈。通过有针对性的抽样从肾病患者中选择参与者。自助联盟,该联盟有来自九家公立医院的4000多名患有慢性肾脏疾病的成员。使用主题内容分析来分析数据。尽管疫苗接种被认为是预防A型流感(H1N1)的最有效方法之一,但本研究中的慢性病患者对此却表示不愿接受。确定了六种阻碍他们接种H1N1疫苗的障碍:对H1N1疫苗的感知为不安全;对疫苗的文化感知为有害;对季节性流感疫苗可提供抗A型流感病毒(H1N1)的信念;难以获得H1N1疫苗的信念;对签约的担忧疫苗接种地点的传染病和财务费用。由于慢性病患者是可能遭受流感严重并发症的高风险人群之一,因此了解阻止其免疫的潜在社会,文化和感性因素对于制定响应其需求的公共卫生政策至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号